These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

289 related items for PubMed ID: 6971058

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Serum SP1 and hCG beta-subunit (hCG beta) levels in choriocarcinoma, invasive mole, and hydatidiform mole--clinical significance of SP1/hCG beta ratio.
    Sakuragi N.
    Gynecol Oncol; 1982 Jun; 13(3):393-8. PubMed ID: 6178652
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Serum SP1, hPL and beta-hCG levels in trophoblastic diseases.
    Zhang WY, Yen GL.
    Chin Med J (Engl); 1991 Dec; 104(12):995-8. PubMed ID: 1723674
    [Abstract] [Full Text] [Related]

  • 8. Pregnancy-specific beta-1-glycoprotein in trophoblastic disease.
    Rutanen EM, Seppälä M.
    J Clin Endocrinol Metab; 1980 Jan; 50(1):57-61. PubMed ID: 6243133
    [No Abstract] [Full Text] [Related]

  • 9. Trophoblastic disease monitoring: Evaluation of pregnancy-specific beta 1-glycoprotein.
    O'Brien TJ, Engvall E, Schlaerth JB, Morrow CP.
    Am J Obstet Gynecol; 1980 Oct 01; 138(3):313-20. PubMed ID: 6251725
    [Abstract] [Full Text] [Related]

  • 10. [HCG and SP1 in serum of patients with hydatidiform mole and chorionepithelioma--relative serum levels of both proteins in correlation to malignancy of the trophoblastic disease].
    Braun P, Leyendecker G.
    Arch Gynecol; 1979 Jul 20; 228(1-4):663-4. PubMed ID: 485549
    [No Abstract] [Full Text] [Related]

  • 11. [Clinical significance of pregnancy-specific beta glycoprotein, human placental lactogen and beta-human chorionic gonadotropin in the serum of patients with trophoblastic diseases].
    Zhang WY.
    Zhonghua Yi Xue Za Zhi; 1989 Apr 20; 69(4):206-8, 16. PubMed ID: 2476204
    [Abstract] [Full Text] [Related]

  • 12. Placental protein 5 in gestational trophoblastic disease: localization and circulating levels.
    Nisbet AD, Bremner RD, Horne CH, Brooker D, Twiggs LB, Okagaki T.
    Am J Obstet Gynecol; 1982 Oct 15; 144(4):396-401. PubMed ID: 6289667
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Monitoring therapy in trophoblastic diseases by radioimmunoassay of pregnancy-specific beta 1-glycoprotein and the beta subunit of human chorionic gonadotropin.
    Than GN, Csaba IF, Bohn H, Szabó DG, Szalmásy M, Menczer G.
    Oncodev Biol Med; 1982 Oct 15; 3(4):315-23. PubMed ID: 6291007
    [Abstract] [Full Text] [Related]

  • 16. [The serum concentration of specific beta 1-glycoprotein in trophoblastic disease].
    Radikov N.
    Akush Ginekol (Sofiia); 1989 Oct 15; 28(2):15-9. PubMed ID: 2548413
    [Abstract] [Full Text] [Related]

  • 17. [Correlation of the trophoblastic beta 1-globulin and chorionic gonadotropin indices and the clinical course of the disease in uterine chorionepithelioma].
    Zhordina KI, Sokolov AV, Kadagidze ZG, Molodyk AA.
    Akush Ginekol (Mosk); 1981 Jul 15; (7):55-6. PubMed ID: 6975579
    [No Abstract] [Full Text] [Related]

  • 18. Plasma beta-subunit human chorionic gonadotropin assay in molar pregnancy and choriocarcinoma.
    Yuen BH, Cannon W, Benedet JL, Boyes DA.
    Am J Obstet Gynecol; 1977 Apr 01; 127(7):711-2. PubMed ID: 557901
    [Abstract] [Full Text] [Related]

  • 19. Radioimmunoassay of the serum free beta-subunit of human chorionic gonadotropin in trophoblastic disease.
    Fan C, Goto S, Furuhashi Y, Tomoda Y.
    J Clin Endocrinol Metab; 1987 Feb 01; 64(2):313-8. PubMed ID: 2432080
    [Abstract] [Full Text] [Related]

  • 20. Elevated sera levels of SP-1 induced by chemotherapy in patients with metastatic gestational trophoblastic diseases.
    Göcze PM, Than GN, Szabò DG, Csaba IF, Bohn H.
    Oncology; 1990 Feb 01; 47(5):406-9. PubMed ID: 1699189
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.